The director of the U.S. National Institutes of Health talks about a newly published expert article explaining that sexual transmission of HIV can't happen if a person is on fully effective treatment.
"PrEP must not be cast as the lone villain in the syphilis crisis, nor MSM engaging in chemsex cast as debauched vectors of transmission."
As part of comprehensive efforts to reduce the number of new HIV infections, some states are innovating to make HIV pre-exposure prophylaxis (PrEP) more accessible to individuals at high risk of HIV.
On Nov. 20, 2018, the U.S. Preventive Services Task Force released a draft recommendation that could transform HIV-1 pre-exposure prophylaxis (PrEP) scale-up in the United States.
"As this HIVR4P conference enters its final day," AVAC writes, "we feel like it's safe to say that this conference heralded an energized, nuanced commitment to choice."
Three of the most recent presidents of the International AIDS Society discussed how far we've come in the three years since they jointly wrote an article in The Lancet calling for greater global access to PrEP.
A new report issued at this year's HIVR4P conference states that flat and/or reduced funding for HIV/AIDS and other global health issues threatens to roll back progress worldwide.